Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
International Journal of Biological Macromolecules|October 24, 2021
Erythrocyte membrane-camouflaged gefitinib/albumin nanoparticles for tumor imaging and targeted therapy against lung cancerQian Wen, Yan Zhang, Tobias Achu Muluh, et al.
ACS Measurement Science Au|July 18, 2022
Characterization of the Presence and Function of Platelet Opioid ReceptorsSarah M Gruba, Danielle H Francis, Audrey F Meyer, et al.
Journal of Nanobiotechnology|January 6, 2026
Bacteria-powered LA@CaDGP biomotor: a multi-modal weapon integrating calcium overload, chemotherapy, and starvation for breast cancer therapyJingrong Huang, Yongcheng Tang, Kewei Xiang, et al.
BMC Geriatrics|June 23, 2026
Gallbladder torsion in multimorbid older adults: a structured narrative review and case reportJi Liu, Zhi-Feng Cheng, Min-Zhi Li, et al.
Scientific Reports|June 21, 2022
Prognostic value of PD-L1 and Siglec-15 expression in patients with nasopharyngeal carcinomaJu Zhao, Hanshan Yang, Hui Hu, et al.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi = Chinese Journal of Schistosomiasis Control|December 15, 2011
[Molluscicidal effect of LDS in mountainous areas of Yunnan Province]Bing-Gui Li, Wen-Bao Li, Yi Dong, et al.
Plos One|June 3, 2015
EETs Attenuate Ox-LDL-Induced LTB4 Production and Activity by Inhibiting p38 MAPK Phosphorylation and 5-LO/BLT1 Receptor Expression in Rat Pulmonary Arterial Endothelial CellsJun-xia Jiang, Shui-juan Zhang, Yao-kang Xiong, et al.
ACS Applied Materials & Interfaces|October 1, 2015
Highly Improved Efficiency of Deep-Blue Fluorescent Polymer Light-Emitting Device Based on a Novel Hole Interface Modifier with 1,3,5-Triazine CoreLianpeng Xia, Yuyuan Xue, Kang Xiong, et al.
Oncology Letters|August 10, 2017
JNK pathway inhibition enhances chemotherapeutic sensitivity to Adriamycin in nasopharyngeal carcinoma cellsYong Liu, Jing Feng, Ming Zhao, et al.
Current Medical Science|July 4, 2021
High-dose Chemotherapy Combined with Autologous Hematopoietic Stem Cell Transplantation as Frontline Therapy for Intermediate/High-risk Diffuse Large B Cell LymphomaQin Wen, Li Gao, Jing-Kang Xiong, et al.
Pageof 8